News Release Details

KP Tissue Releases Third Quarter 2018 Financial Results

November 8, 2018 at 7:00 AM EST

Moving Forward with Long-Term Strategic Initiatives

MISSISSAUGA, Ontario, Nov. 08, 2018 (GLOBE NEWSWIRE) -- KP Tissue Inc. (KPT) (TSX: KPT) reports the Q3 2018 financial and operational results of KPT and Kruger Products L.P. (KPLP). Kruger Products is Canada's leading manufacturer of quality tissue products for the Consumer market (Cashmere, Purex, SpongeTowels, Scotties, and White Swan) and the Away-From-Home market, and continues to grow in the U.S. Consumer tissue business with the White Cloud® brand and premium private label products. KPT currently holds a 15.8% interest in KPLP.

KPLP Q3 2018 Business and Financial Highlights

  • Revenue increased by 3.6% to $348.4 million in Q3 2018 compared to Q3 2017
  • Adjusted EBITDA was $28.3 million in Q3 2018 compared to $39.4 million in Q3 2017
  • Pulp and freight costs continued to escalate in the quarter
  • Announced plans to invest $575 million to build a second TAD paper machine and state-of-the-art plant
  • Declared a quarterly dividend of $0.18 per share to be paid on January 15, 2019

“Our results for the third quarter reflect continued negative impact from high pulp prices and freight costs. Despite this difficult cost environment in 2018, we are undertaking several key initiatives that will strengthen our business over the longer term, and reinforce our leadership position in the market,” said Dino Bianco, CEO of KP Tissue and KPLP.

“The recent selling price increase announced in our Canadian consumer business will take effect in the fourth quarter and is expected to fully materialize in the first quarter of 2019.  Our decision during the quarter to proceed with the $575 millionTAD2 Project is central to our long-term North American growth strategy in the ultra-premium paper tissue segment.  We also have further plans to optimize our operational network.

“We are confident that we have the right vision and strategy to move the Company forward and create increased value for our shareholders,” concluded Mr. Bianco.

Outlook

KPLP continues to have strong long-term business fundamentals. However, due to continued pressure from high input costs Q4 2018 Adjusted EBITDA is expected to be significantly lower than Q4 2017 which was $33.7 million.

TAD2 Project

On August 16, 2018, KPLP announced its plan for a capital investment of $575 million in the Brompton area of Sherbrooke, Quebec, to build a new, state-of-the art tissue plant featuring Canada’s largest and most modern TAD paper machine (TAD2) along with related converting equipment and infrastructure (the TAD2 Project).  The TAD2 Project is projected to produce at maturity approximately 70,000 metric tonnes per annum of bathroom tissue and paper towels which will enable KPLP to increase its offering of ultra-premium and innovative tissue products under the Cashmere, Sponge Towels and Purex brands.  Construction of the TAD2 Project is anticipated to begin in early 2019 and commence production in early 2021.

The TAD2 Project is expected to be financed with 40% equity and 60% debt in a newly-created, wholly-owned subsidiary of KPLP, Kruger Products Sherbrooke Inc. (KPSI), which will construct and operate the TAD2 Project.  KPLP believes that negotiations and documentation are close to being finalized for long-term construction financing of KPSI for the anticipated $345 million debt portion. The $230 million equity portion of the financing is expected to be funded by the Government of Quebec through Investissement Quebec (IQ), which has agreed to invest $105 million by way of subscription to a convertible debenture, and by KPLP, which intends to acquire an equity interest in KPSI for the remaining $125 million of the equity component.

The financing structure for the TAD2 Project is anticipated to be non-dilutive to KPT shareholders. KPLP plans to finance its equity investment in KPSI with long-term senior secured fixed debt for approximately $63 million, and the remainder by establishing an accounts receivable factoring program and from cash.  Upon closing of the construction financing, KPLP intends to fund half of the $125 million of equity into KPSI, with the remainder to be funded over the following two years. The various debt financings, whether at the KPLP or KPSI level, are expected to close prior to year-end 2018. The weighted average cost of capital for the entire $575 million of TAD2 financing is anticipated to be in the 5-7% range. In addition, the existing KTG debt is expected to be refinanced with an 18 year term loan concurrently with the closing of the TAD2 financing, with an anticipated fixed interest cost in the 6-8% range, which is significantly less than the approximate 14-15% cost under the current KTG debt incurred for the TAD1 Project.

The IQ convertible debenture will carry a 3% capitalized fixed interest rate for a term of ten years, and will be required to be redeemed on a monthly basis by KPLP commencing 36 months from the date of issuance.  In the event of a failure of either KPLP or Kruger Inc. to make a monthly redemption in accordance with the terms of the debenture, IQ will have a conversion right in respect of the portion of the balance of the debenture that is not paid on terms of conversion that would provide IQ with a 48% equity interest in KPSI if the entirety of the debenture were to be converted.

KPLP Q3 2018 Financial Results
Revenue in Q3 2018 was $348.4 million, compared to $336.3 million in Q3 2017, an increase of $12.1 million or 3.6%. The increase in revenue was primarily due to the following factors: increased sales volume in the U.S. and Mexico, partially offset by a decrease in sales volume in Canada; the Consumer selling price increase in Canada in Q4 2017; and the favourable impact of foreign exchange fluctuations on U.S. dollar sales.

Cost of sales in Q3 2018 increased to $312.6 million from $290.8 million in Q3 2017. Manufacturing costs increased primarily due to significantly higher pulp and sorted office waste costs, increased sales volume and the unfavourable impact of foreign exchange fluctuations on U.S. dollar denominated costs. Freight costs increased primarily due to higher carrier rates and increased sales volume. As a percentage of revenue, cost of sales were 89.7% in Q3 2018 compared to 86.5% in Q3 2017.

Selling, general and administrative (SG&A) expenses in Q3 2018 were $20.5 million, compared to $20.7 million in Q3 2017. As a percentage of revenue, SG&A expenses were 5.9% in Q3 2018, compared to 6.2% in Q3 2017.

Adjusted EBITDA in Q3 2018 was $28.3 million, compared to $39.4 million in Q3 2017, lower by $11.1 million or 28.2%, due primarily to significantly higher fibre costs and increased freight costs, unfavourable sales mix and the net unfavourable impact of foreign exchange fluctuations. These were partially offset by the Q4 2017 Canadian Consumer selling price increase.

Net income in Q3 2018 was $4.2 million, compared to $16.5 million in Q3 2017, primarily due to the factors that resulted in a lower Adjusted EBITDA set out above, as well as an increase in interest expense of $1.6 million, an increase in the change in amortized cost of partnership units liability of $0.9 million and a change in foreign exchange gain (loss) of $0.7 million. These items were partially offset by lower depreciation expense of $1.6 million and a decrease in income taxes of $0.7 million.

Total liquidity, representing cash and cash equivalents and availability under the credit line within covenant limitations, was $63.6 million as of September 30, 2018, compared to $64.5 million as of July 1, 2018.

KPT Q3 2018 Financial Results
KPT incurred a net loss of $0.8 million in Q3 2018. Included in the net loss was $0.7 million representing KPT’s share of KPLP’s income. The income was reduced by depreciation expense of $1.4 million related to adjustments to carrying amounts on acquisition, partially offset by an income tax expense of $0.1 million.

Dividends on Common Shares                                                     
The Board of Directors of KPT declared a quarterly dividend of $0.18 per share to be paid on January 15, 2019 to shareholders of record at the close of business on December 31, 2018.

Additional Information
For additional information please refer to Management’s Discussion and Analysis (MD&A) of KPT and KPLP for the third quarter ended September 30, 2018 available on SEDAR at www.sedar.com or our website at www.kptissueinc.com.

Third Quarter Results Conference Call Information
KPT will hold its third quarter conference call on Thursday, November 8, 2018 at 8:30 a.m. Eastern Time.

Via telephone:  1-877-223-4471 or 647-788-4922

Via the internet at: www.kptissueinc.com

Presentation material referenced during the conference call will be available at www.kptissueinc.com.

A rebroadcast of the conference call will be available until midnight, November 15, 2018 by dialing 800-585-8367 or 416-621-4642 and entering passcode 1279747.

The replay of the webcast will remain available on the website until midnight, November 15, 2018.

About KP Tissue Inc. (KPT)
KPT was created to acquire, and its business is limited to holding, a limited partnership interest in KPLP, which is accounted for as an investment on the equity basis. KPT currently holds a 15.8% interest in KPLP. For more information visit www.kptissueinc.com.

About Kruger Products L.P. (KPLP)
KPLP is Canada's leading manufacturer of quality tissue products for household, industrial and commercial use. KPLP serves the Canadian consumer market with such well-known brands as Cashmere®, Purex®, SpongeTowels®, Scotties® and White Swan®. In the U.S., KPLP manufactures the White Cloud® brand, as well as many private label products. The Away-From-Home division manufactures and distributes high-quality, cost-effective product solutions to a wide range of commercial and public entities. KPLP has approximately 2,500 employees and operates eight FSC® COC-certified (FSC® C-104904) production facilities in North America.  For more information visit www.krugerproducts.ca.

Non-IFRS Measures
This press release uses certain non-IFRS financial measures which KPLP believes provide useful information to management of KPLP and the readers of the financial information in measuring the financial performance and financial condition of KPLP. These measures do not have a standardized meaning prescribed by IFRS and therefore may not be comparable to similarly titled measures presented by other companies. An example of such a measure is Adjusted EBITDA. Beginning with Q4 2015 in accordance with Canadian Securities Administrators Staff Notice 52-306 (Revised), we have referenced Adjusted EBITDA as a non-IFRS financial measure. This term replaces the previously referenced non-IFRS financial measure EBITDA. Our definition of Adjusted EBITDA is unchanged from our former definition of EBITDA. Accordingly, this change in terminology has no impact on our reported financial results for prior periods. Adjusted EBITDA is not a measurement of operating performance computed in accordance with IFRS and should not be considered as a substitute for operating income, net income or cash flows from operating activities computed in accordance with IFRS. “Adjusted EBITDA” is calculated by KPLP as net income (loss) before (i) interest expense, (ii) income taxes, (iii) depreciation, (iv) amortization, (v) impairment (gain on sale) of non-financial assets, (vi) loss (gain) on disposal of property, plant and equipment, (vii) foreign exchange loss (gain), (viii) costs related to restructuring activities, (ix) changes in amortized cost of Partnership units liability, and (x) one-time costs due to pension revaluations related to past service. A reconciliation of Adjusted EBITDA to the relevant reported results can be found in the MD&A of KPT and KPLP for the third quarter ended September 30, 2018 available on SEDAR at www.sedar.com.

Forward-Looking Statements
Certain statements in this press release about KPT's and KPLP's current and future plans, expectations and intentions, results, levels of activity, performance, goals or achievements or any other future events or developments constitute forward-looking statements. Forward-looking statements in this press release include, but are not limited to, items such as: the potential construction of the TAD2 paper machine, the timing of commencement of construction of TAD2, the timing of commencement of production of TAD2, the anticipated capacity of TAD2, the benefits of TAD2, the cost of TAD2 and the anticipated financing structure and timing and cost of financing for TAD2, and KPLP’s future business strategy. The words "may", "will", "would", "should", "could", "expects", "plans", "intends", "trends", "indications", "anticipates", "believes", "estimates", "predicts", "likely" or "potential" or the negative or other variations of these words or other comparable words or phrases, are intended to identify forward-looking statements. The forward-looking statements are based on certain key expectations and assumptions made by KPT or KPLP, including expectations and assumptions concerning: the entering into of satisfactory definitive agreements with third parties for the financing of TAD2; the on-time and on-budget construction of TAD2; the impact of the TAD2 Project on Adjusted EBITDA; the expectation of continued growth in sales of TAD products in the U.S.; a successful ramp-up of the Crabtree paper machine; improved performance of the Away-From-Home business; and expanded distribution of White Cloud to select U.S. retailers. Although KPT and KPLP believe that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking statements since no assurance can be given that such expectations and assumptions will prove to be correct.

The outlook provided in respect of Adjusted EBITDA for Q4 2018 is forward-looking information and is subject to the risk and uncertainties referred to below. The purpose of the outlook is to provide the reader with an indication of management’s expectations, at the date of this press release, regarding KPLP’s future financial performance. Readers are cautioned that this information may not be appropriate for other purposes.  

Many factors could cause KPLP’s actual results, level of activity, performance or achievements or future events or developments (which could in turn affect the economic benefits derived from the corporation’s economic interest in KPLP) to differ materially from those expressed or implied by the forward-looking statements, including, without limitation, the following factors, which are discussed in greater detail in the “Risk Factors – Risks Related to KPLP’s Business” section of the KPT Annual Information Form dated March 9, 2018 available on SEDAR at www.sedar.com: Kruger Inc.’s influence over KPLP; KPLP’s reliance on Kruger Inc.; consequences of an event of insolvency relating to Kruger Inc.; risks associated with the Memphis TAD machine; operational risks; Gatineau Plant land lease; significant increases in input costs; reduction in supply of fibre; increased pricing pressure and intense competition; KPLP’s inability to innovate effectively; adverse economic conditions; dependence on key retail trade customers; damage to the reputation of KPLP or KPLP’s brands; KPLP’s sales being less than anticipated; KPLP’s failure to implement its business and operating strategies; KPLP’s obligation to make regular capital expenditures; KPLP’s entering into unsuccessful acquisitions; KPLP’s dependence on key personnel; KPLP’s inability to retain its existing customers or obtain new customers; KPLP’s loss of key suppliers; KPLP’s failure to adequately protect its intellectual property rights; KPLP’s reliance on third party intellectual property licenses; adverse litigation and other claims affecting KPLP; material expenditures due to comprehensive environmental regulation affecting KPLP’s cash flow; KPLP’s pension obligations are significant and can be materially higher than predicted if KPLP Management’s underlying assumptions are incorrect; labour disputes adversely affecting KPLP’s cost structure and KPLP’s ability to run its plants; exchange rate and U.S. competitors; KPLP’s inability to service all of its indebtedness; exposure to potential consumer product liability; covenant compliance; interest rate and refinancing risk; and risks relating to information technology, cyber-security, insurance, internal controls, and trade.

Readers should not place undue reliance on forward-looking statements made herein. The forward-looking information contained herein is expressly qualified in its entirety by this cautionary statement. The forward-looking information contained herein is made as of the date of press release and KPT undertakes no obligation to publicly update such forward-looking information to reflect new information, subsequent or otherwise, unless required by applicable securities laws.

INFORMATION:

Francois Paroyan
General Counsel and Corporate Secretary
KP Tissue Inc.
Tel.: 905.812.6936
francois.paroyan@krugerproducts.ca

INVESTORS:

Mike Baldesarra
Director of Investor Relations
KP Tissue Inc.
Tel.: 905.812.6962
IR@KPTissueinc.com

Kruger Products L.P.
Unaudited Condensed Consolidated Statement of Financial Position
(thousands of Canadian dollars) 
             
    September 30, 2018     December 31, 2017  
    $     $  
Assets          
Current assets          
  Cash and cash equivalents   26,929       8,837  
  Trade and other receivables    149,825       113,194  
  Receivables from related parties   217       85  
  Current portion of advances to partners   6,199       1,928  
  Inventories    199,912       192,394  
  Income tax recoverable    402       522  
  Prepaid expenses    10,417       8,007  
      393,901       324,967  
Non-current assets          
  Advances to partners   -        4,489  
  Property, plant and equipment    766,032       761,610  
  Other long-term assets    10       6,331  
  Goodwill   160,939       160,939  
  Intangible assets    15,272       15,327  
  Deferred income taxes    29,902       26,092  
Total assets   1,366,056       1,299,755  
             
Liabilities          
Current liabilities          
  Bank indebtedness   -        9,051  
  Trade and other payables    195,843       190,698  
  Payables to related parties   4,546       2,596  
  Income tax payable   647       498  
  Distributions payable    10,620       10,382  
  Current portion of provisions    456       333  
  Current portion of long-term debt    202,649       190,947  
      414,761       404,505  
Non-current liabilities          
  Long-term debt    286,738       225,368  
  Provisions    5,850       5,973  
  Pensions    91,870       119,558  
  Post-retirement benefits    53,812       60,457  
  Liabilities to non-unitholders   853,031       815,861  
  Current portion of Partnership units liability    1,928       1,928  
  Long-term portion of Partnership units liability    157,169       158,381  
  Total Partnership units liability    159,097       160,309  
Total liabilities   1,012,128       976,170  
             
Equity          
  Partnership units   371,401       356,240  
  Deficit   (94,507 )     (99,742 )
  Accumulated other comprehensive income   77,034       67,087  
Total equity   353,928       323,585  
Total equity and liabilities   1,366,056       1,299,755  
             
             


Kruger Products L.P.
Unaudited Condensed Consolidated Statement of Comprehensive Income (Loss)
(thousands of Canadian dollars)
                         
                         
    3-month
period ended
September 30, 2018
    3-month
period ended
September 24, 2017
    9-month
period ended
September 30, 2018
    9-month
period ended
September 24, 2017
 
    $     $     $     $  
                         
Revenue      348,420       336,284       1,010,928       939,943  
                         
Expenses                        
Cost of sales      312,595       290,777       904,888       802,108  
Selling, general and administrative expenses      20,573       20,726       63,594       66,467  
(Gain) loss on sale of non-financial assets     1       (12 )     (207 )     (80 )
Restructuring costs, net     -        (245 )     1       (234 )
                         
Operating income     15,251       25,038       42,652       71,682  
                         
Interest expense     12,065       10,533       35,876       31,554  
Other (income) expense      (465 )     (2,103 )     544       1,860  
                         
Income before income taxes     3,651       16,608       6,232       38,268  
                         
Income taxes      (545 )     158       (1,185 )     4,922  
                         
Net income for the period     4,196       16,450       7,417       33,346  
                         
Other comprehensive income (loss)                        
Items that will not be reclassified to net income:                        
Remeasurements of pensions     11,051       (5,424 )     28,722       (20,647 )
Remeasurements of post-retirement benefits     7,068       2,929       7,490       (272 )
Items that may be subsequently reclassified to net income:                        
Cumulative translation adjustment     (4,963 )     (23,774 )     9,947       (27,119 )
                         
Total other comprehensive income (loss) for the period     13,156       (26,269 )     46,159       (48,038 )
                         
Comprehensive income (loss) for the period     17,352       (9,819 )     53,576       (14,692 )


Kruger Products L.P.
Unaudited Condensed Consolidated Statement of Cash Flows
(thousands of Canadian dollars)
                       
                       
  3-month
period ended
September 30, 2018
    3-month
period ended
September 24, 2017
    9-month
period ended
September 30, 2018
    9-month
period ended
September 24, 2017
 
  $     $     $     $  
Cash flows from (used in) operating activities                      
Net income for the period   4,196       16,450       7,417       33,346  
Items not affecting cash                      
Depreciation   12,640       14,350       38,023       38,414  
Amortization    345       286       1,078       775  
Loss (gain) on sale of property, plant and equipment   -        -        434       (2 )
Change in amortized cost of Partnership units liability   -        (882 )     716       4,178  
Foreign exchange loss (gain)   (534 )     (1,221 )     123       (2,318 )
Change in fair value of derivatives   69       -        (295 )     -   
Interest expense   12,065       10,533       35,876       31,554  
Pension and post-retirement benefits   2,931       2,513       9,850       7,539  
Provisions    25       (127 )     86       211  
Income taxes   (545 )     158       (1,185 )     4,922  
Loss (gain) on sale of non-financial assets   1       (12 )     (207 )     (80 )
Total items not affecting cash   26,997       25,598       84,499       85,193  
                       
Net change in non-cash working capital    6,291       5,130       (34,609 )     (25,959 )
Contributions to pension and post-retirement benefit plans   (4,169 )     (3,735 )     (12,308 )     (11,406 )
Provisions paid   -        (565 )     (247 )     (1,015 )
Income tax payments   (514 )     (115 )     (1,863 )     (3,169 )
                       
Net cash from operating activities   32,801       42,763       42,889       76,990  
                       
Cash flows from (used in) investing activities                      
Purchases of property, plant and equipment   (7,551 )     (12,033 )     (35,869 )     (50,278 )
Capitalized interest paid   -        (116 )     -        (497 )
Government assistance received   1,171       923       1,182       3,872  
Purchases of software   2       (460 )     (1,023 )     (460 )
Proceeds on sale of property, plant and equipment   (1 )     14       323       1,184  
                       
Net cash used in investing activities   (6,379 )     (11,672 )     (35,387 )     (46,179 )
                       
Cash flows from (used in) financing activities                      
Proceeds from long-term debt   (112 )     (5,893 )     195,001       20,877  
Repayment of long-term debt   (408 )     (4,749 )     (127,516 )     (5,250 )
Payment of deferred financing fees   (186 )     -        (4,103 )     (12 )
Interest paid on long-term debt   (8,784 )     (7,819 )     (25,660 )     (18,930 )
Distributions and advances paid, net   (5,609 )     (8,263 )     (18,374 )     (25,992 )
                       
Net cash from (used in) financing activities   (15,099 )     (26,724 )     19,348       (29,307 )
                       
Effect of exchange rate changes on cash and cash equivalents held in foreign currency   (186 )     (1,924 )     293       (2,011 )
                       
Increase (decrease) in cash and cash equivalents during the period   11,137       2,443       27,143       (507 )
                       
Cash and cash equivalents - Beginning of period   15,792       24,554       (214 )     27,504  
                       
Cash and cash equivalents - End of period   26,929       26,997       26,929       26,997  


Kruger Products L.P.
Segment and Geographic Results
(thousands of Canadian dollars)
                         
  3-month
period ended
September 30, 2018
    3-month
period ended
September 24, 2017
    9-month
period ended
September 30, 2018
    9-month
period ended
September 24, 2017
   
  $     $     $     $    
                         
Segment Information                        
                         
Segment Revenue                        
Consumer   287,090       272,917       832,281       763,996    
AFH   59,428       62,497       172,537       171,090    
Other   1,902       870       6,110       4,857    
                         
Total segment revenue   348,420       336,284       1,010,928       939,943    
                         
Segment Adjusted EBITDA                        
Consumer   35,317       38,077       97,391       105,951    
AFH   (4,830 )     1,852       (8,263 )     4,840    
Other   (2,249 )     (512 )     (7,147 )     (236 )  
                         
Total segment Adjusted EBITDA   28,238       39,417       81,981       110,555    
                         
Reconciliation to Net Income:                        
                         
Depreciation and amortization   12,986       14,636       39,101       39,189    
Interest expense   12,065       10,533       35,876       31,554    
Change in amortized cost of Partnership units liability   -       (882 )     716       4,178    
Change in fair value of derivatives   69       -       (295 )     -    
(Gain) loss on sale of property, plant and equipment   -       -       434       (2 )  
(Gain) loss on sale of non-financial assets   1       (12 )     (207 )     (80 )  
Restructuring costs, net   -       (245 )     1       (234 )  
Foreign exchange (gain) loss   (534 )     (1,221 )     123       (2,318 )  
                         
Income before income taxes   3,651       16,608       6,232       38,268    
                         
Income taxes   (545 )     158       (1,185 )     4,922    
                         
Net income    4,196       16,450       7,417       33,346    
                         
Geographic Revenue                        
                         
Canada   205,082       209,289       596,075       570,949    
U.S.   119,727       113,157       351,631       332,710    
Mexico   23,611       13,838       63,222       36,284    
                         
Total revenue   348,420       336,284       1,010,928       939,943    
                         


KP Tissue Inc.
Unaudited Condensed Statement of Financial Position
(thousands of Canadian dollars)
             
  September 30, 2018     December 31, 2017    
  $     $    
Assets            
             
Current assets            
Distributions receivable   1,683       1,658    
Receivable from Partnership   614       -     
Income tax recoverable   527       826    
    2,824       2,484    
             
Non-current assets            
Investment in associate   98,458       98,674    
             
Total Assets   101,282       101,158    
             
Liabilities            
             
Current liabilities            
Dividend payable   1,683       1,658    
Payable to Partnership   -        52    
Current portion of advances from Partnership   1,005       309    
    2,688       2,019    
Non-current liabilities            
Advances from Partnership   -        731    
Deferred income taxes    2,535       1,483    
             
Total liabilities   5,223       4,233    
             
Equity            
             
Common shares   16,577       15,014    
Contributed surplus    144,819       144,819    
Deficit   (79,035 )     (74,952 )  
Accumulated other comprehensive income   13,698       12,044    
             
Total equity   96,059       96,925    
             
Total liabilities and equity   101,282       101,158    


KP Tissue Inc.
Unaudited Condensed Statement of Comprehensive Income (Loss)
(thousands of Canadian dollars, except share and per share amounts)
 
  3-month
period ended
September 30, 2018
    3-month
period ended
September 24, 2017
    9-month
period ended
September 30, 2018
    9-month
period ended
September 24, 2017
 
  $     $     $     $  
                       
Equity Income (loss)   (789 )     1,179       (3,186 )     931  
                       
Dilution gain    49       39       138       136  
                       
Income (loss) before income taxes   (740 )     1,218       (3,048 )     1,067  
                       
Income taxes   92       1,288       (49 )     2,288  
                       
Net loss for the period   (832 )     (70 )     (2,999 )     (1,221 )
                       
Other comprehensive income (loss)                      
net of tax expense (recovery)                      
Items that will not be reclassified to net loss:                      
Remeasurements of pensions    1,526       (755 )     3,974       (2,885 )
Remeasurements of post-retirement benefits    701       287       760       (27 )
Items that may be subsequently reclassified to net loss:                      
Cumulative translation adjustment    (851 )     (4,086 )     1,654       (4,705 )
                       
Total other comprehensive income (loss) for the period   1,376       (4,554 )     6,388       (7,617 )
                       
Comprehensive income (loss) for the period   544       (4,624 )     3,389       (8,838 )
                       
Basic loss per share   (0.09 )     (0.01 )     (0.32 )     (0.13 )
                       
Weighted average number of shares outstanding   9,341,392       9,176,138       9,292,592       9,146,312  


KP Tissue Inc.
Unaudited Condensed Statement of Cash Flows
(thousands of Canadian dollars)
                       
  3-month
period ended
September 30, 2018
    3-month
period ended
September 24, 2017
    9-month
period ended
September 30, 2018
    9-month
period ended
September 24, 2017
 
  $     $     $     $  
Cash flows from (used in) operating activities                      
Net loss for the period   (832 )     (70 )     (2,999 )     (1,221 )
Items not affecting cash                      
Equity (income) loss   789       (1,179 )     3,186       (931 )
Dilution gain    (49 )     (39 )     (138 )     (136 )
Income taxes   92       1,288       (49 )     2,288  
Total items not affecting cash   832       70       2,999       1,221  
                       
Net change in non-cash working capital    -       (219 )     -       478  
Tax payments   -       (225 )     (274 )     (1,999 )
Tax Distribution received   -       -       -       481  
Advances received   -       444       274       1,040  
                       
Net cash from (used in) operating activities   -       -       -       -  
                       
Cash flows from investing activites                      
Partnership unit distributions received   1,181       1,218       3,482       3,586  
                       
Net cash from investing activities   1,181       1,218       3,482       3,586  
                       
Cash flows used in financing activities                      
Dividends paid   (1,181 )     (1,218 )     (3,482 )     (3,586 )
                       
Net cash used in financing activities   (1,181 )     (1,218 )     (3,482 )     (3,586 )
                       
Increase (decrease) in cash and cash equivalents during the period   -       -       -       -  
                       
Cash and cash equivalents - Beginning of period   -       -       -       -  
                       
Cash and cash equivalents - End of period   -       -       -       -  


KP Tissue Inc..jpg

Source: KP Tissue Inc.